---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-076515"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2024-09-06T23:59:59+00:00"
generated_at: "2026-05-31T06:07:35.184562+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals raises ~$4M in private placement of common stock equivalents and warrants

## Summary
- Issued 2,898,551 pre-funded warrants and series A/B warrants at $1.38/share for gross proceeds of ~$4M.
- Placement closed Sept. 5, 2024; H.C. Wainwright acted as exclusive placement agent.
- Net proceeds to fund working capital, Arakoda commercialization, and R&D programs.
- Warrants exercisable upon stockholder approval; Series A expire 5 years, Series B expire 18 months thereafter.

## SEC filing metadata
- accession: 0001213900-24-076515
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2024-09-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390024076515/0001213900-24-076515-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390024076515/ea0213757-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-076515
- JSON: https://secwatch.observer/filing/0001213900-24-076515.json
- Plain text: https://secwatch.observer/filing/0001213900-24-076515.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.